Literature DB >> 23951434

Potential therapy for Rubinstein-Taybi syndrome.

.   

Abstract

Entities:  

Year:  2012        PMID： 23951434      PMCID： PMC3727767          DOI： 10.1038/bonekey.2012.30

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN： 2047-6396


× No keyword cloud information.
  1 in total

1.  Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice.

Authors:  Jae-Hyuck Shim; Matthew B Greenblatt; Anju Singh; Nicholas Brady; Dorothy Hu; Rebecca Drapp; Wataru Ogawa; Masato Kasuga; Tetsuo Noda; Sang-Hwa Yang; Sang-Kyou Lee; Vivienne I Rebel; Laurie H Glimcher
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.